During the month of June, investors were able to learn a lot more about the upcoming edibles market in Canada.

Marijuana-infused and edible items will be legalized on October 17 of this year. However, the government is projecting that sales will not kick off until mid-December.

Despite the expected slow ramp up, this market is set to play a critical role in the development of marijuana producers.

The government has been cautious, indicating that the initial rollout will take time as all the necessary parties start to get familiarized with the new set of cannabis products.

Similar to what happened with last year’s legalization of adult-use products, these new items will face restrictions on marketing, promotion and packaging. Every product will adhere to a limit of 10 milligrams of tetrahydrocannabinol (THC). Producers will be required to indicate in the labeling the percentages of THC or cannabidiol included.

“Additionally, as with any new regulatory framework, federally licensed processors will need time to become familiar with and prepare to comply with the new rules, and to produce new products,” the federal government said.

“Provincially or territorially authorized distributors and retailers will also need time to purchase and obtain the new products and make them available for sale.”

New reports shed light on importance of edibles

Deloitte issued its official projections on the impact of the edibles market on the Canadian economy. As per the study, the entire market for edible and infused products will be worth C$2.7 billion per year.

The researchers project that edible items alone will command a market leading share and rake in C$1.6 billion per year in Canada. Marijuana infused beverages, an item facing the pressure of significant investment from producers and alcohol companies, are set to represent C$529 million per year.

“According to our research and stakeholder interviews, much of this economic boost will be on top of current cannabis product spending,” Jennifer Lee, partner at Deloitte and the firm’s cannabis leader for Canada, said in a press release.

The second report offers a closer look into the edibles market and is a collaboration between Lift & Co. (TSXV:LIFT,OTCQB:LFCOF) and EY. This study focuses on consumer trends related to the new sector, as displayed during a presentation at the Lift & Co. Cannabis Expo in Toronto.

Ashley Chiu, cannabis strategic growth and risk leader at EY, told the Investing News Network (INN) that she expects the new edibles market to cause the entry of 1.5 million new consumers into the overall cannabis market in Canada.

Chiu explained to INN that the study used a new breakdown of consumers to better understand the needs and which groups offer more upside. The consumer categories are canna-savvy, canna-casual, canna-curious and unconvinced.

Watch the video above for more on what happened in cannabis during the month of June.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

US Election 2020 and Cannabis

Investing in cannabis? Read what experts have to say about cannabis and the US Election!

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less